State of the State in TB Control
|
|
- Brenda Poole
- 5 years ago
- Views:
Transcription
1 State of the State in TB Control Jason Stout, MD, MHS Wake County TB Medical Consultant NC TB Medical Director Division of Infectious Diseases, Duke University Medical Center
2 Disclosures-Funding NIH (grant) CDC (contract) JHP Pharmaceuticals (grant) UpToDate (card author) Novella/NKT Therapeutics (DSMB)
3 In 2016 our TB was high, Ten percent increase, cases weren t shy. In the US the decline was said to have stalled, Not much of a drop in the cases at all. Molecular tools made life much better, Despite interference from hurricane weather. High workload offset by Skyping the meds, Though rising addiction fills us with dread. TB nurses are sorely required, Though many are saying I just retired!
4 TB News in 2016 Case numbers higher in NC Spotlight on latent TB in the US More evidence for rifamycin-based LTBI rx TB outbreaks near and far New tools for understanding TB TB and pregnancy
5 TB Incidence in the US MMWR 2017; 66: 289
6 NC TB cases # Cases Year
7 Latent TB in the US CDC conducts NHANES survey about every 10 years Information about many population health parameters Most recent estimate 4.2% of population in 2000 Had declined by ~60% during the previous 28 yrs Data from recently analyzed
8 Latent TB in the US NHANES Population-based sample Did both TST and QFT-IT in participants age 6 and older (prior years only did TST) Estimates based on population-weighted results Mancuso et al., AJRCCM 2016; 194: 501
9
10
11
12
13
14
15 Mancuso et al., AJRCCM 2016; 194: 501
16 Mancuso et al., AJRCCM 2016; 194: 501
17 LTBI Gets Its Due USPTF reviewed the evidence on screening for latent TB in primary care This is important because under ACA, screening tests with an A or B rating are paid for Consider benefits, harms, but not cost JAMA 2016; 316: 962
18 LTBI Gets Its Due Populations at increased risk: Foreign-born in high-prevalence country Current or former residence in congregate setting Homeless shelter Correctional facility Estimated risk/benefit: TB cases prevented per 100,000 screened 7-67 cases of hepatotoxicity per 100,000 screened JAMA 2016; 316: 962
19 LTBI Gets Its Due LTBI screening received a B rating Moderate certainty of a moderate net benefit in screening asymptomatic persons for LTBI JAMA 2016; 316: 962
20 Rifamycins for LTBI INH still listed as first-line in CDC guidelines In NC, have been moving toward short-course regimens 4 mos rifampin 12 weeks isoniazid/rifapentine Better completion rates and tolerability But how does efficacy compare?
21 Rifamycins for LTBI Network meta-analysis examining current LTBI regimens Conventional meta-analysis: Summarize all studies comparing A to B Network meta-analysis: Combine studies comparing different treatments So if A is better than B and B is better than C, A is probably better than C
22 Annals Int Med 2017; 167: 248
23 Annals Int Med 2017; 167: 248
24 Annals Int Med 2017; 167: 248
25 Rifamycins for LTBI Large RCT comparing 4 mos RIF with 9 mos INH for efficacy was recently completed Results hopefully available in 2018 For now, even more confidence that RIF works
26
27 Atlanta Outbreak Longstanding issue with homeless shelters in Atlanta Lots of HIV+ persons not on treatment hanging out at shelters Guess what? Powell et al, Public Health Reports 2017; 132: 231
28 Powell et al, Public Health Reports 2017; 132: 231
29 US TB Outbreaks CDC did a retrospective evaluation of TB outbreaks for which they provided on-site assistance Defined an outbreak as 3 or more cases related by transmission (genotype and epi links) Mindra et al, Public Health Reports 2017; 132: 157
30 US TB Outbreaks Mindra et al, Public Health Reports 2017; 132: 157
31 US TB Outbreaks Mindra et al, Public Health Reports 2017; 132: 157
32 US TB Outbreaks Mindra et al, Public Health Reports 2017; 132: 157
33 Atlanta Outbreak Almost all cases were homeless 100% INH-monoresistant High prevalence of HIV 56% HIV+ initial phase 35% quiescent phase 30% recrudescent phase Of those with HIV, most not on meds Powell et al, Public Health Reports 2017; 132: 231
34 Atlanta Outbreak 12 patients died, 10 of TB All but 2 of remainder completed treatment 59% unable to name any contacts County health dept evaluated 1360 homeless people plus 916 known contacts 1/14-6/ had LTBI 58 of these either were receiving or completed 4 mos rifampin Powell et al, Public Health Reports 2017; 132: 231
35 Atlanta Outbreak Powell et al, Public Health Reports 2017; 132: 231
36
37 If you think that s bad Widespread epidemic of XDR TB ongoing in South Africa Cases have increased since 2002 Not entirely clear why
38 XDR in South Africa Prospective study of 404 XDR patients diagnosed in KwaZulu-Natal province, South Africa Did interviews and reviewed medical records Also did genotyping of TB isolates NEJM 2017; 376: 243
39 XDR in South Africa KZN has population of 10.3 million Majority live in rural areas Estimated that about half the XDR burden in S Africa is in this province Highest rates of TB (1076 per 100,000) and HIV (16.9% prevalence) in South Africa NEJM 2017; 376: 243
40 NEJM 2017; 376: 243
41 XDR in South Africa Majority of XDR was transmitted 124 with acquired resistance 280 with transmitted Majority of patients (77%) had HIV Median CD4 in 300s About 60% on antiretroviral meds 60% of pts with transmitted resistance had a history of prior TB treatment, mostly for DS NEJM 2017; 376: 243
42 XDR in South Africa Transmitted in both hospital and community settings Epi links noted in 30% of participants Lots of little networks NEJM 2017; 376: 243
43 XDR in South Africa NEJM 2017; 376: 243
44 Genes and TB Meningitis TB meningitis is a bad disease ~30% mortality Many who survive are disabled Corticosteroids are routinely recommended Reduce inflammation Seem to improve survival Steroids may not benefit everyone equally
45 Genes and TB Meningitis Leukotriene A(4) hydrolase (LTA4H) gene controls balance of pro- and antiinflammatory eicosanoids A single nucleotide polymorphism in the promoter for this gene regulates its activity Tobin et al, Cell 2012; 148(3): 434
46 Tobin et al, Cell 2012; 148(3): 434
47 Tobin et al, Cell 2012; 148(3): 434
48 Genes and TB Meningitis New prospective study to examine this association further Enrolled 764 Vietnamese adults into a randomized trial of intensified TB treatment All patients received dexamethasone Prospectively genotyped all patients Thuong et al, J Inf Dis 2017; 215: 1020
49 Thuong et al, J Inf Dis 2017; 215: 1020
50 Thuong et al, J Inf Dis 2017; 215: 1020
51 Genes and TB Meningitis Both LTA4H genotype and HIV influence the amount of inflammation in spinal fluid and mortality from TB meningitis Practical implication: If we could rapidly genotype patients, maybe we could select which patients would benefit from steroids Thuong et al, J Inf Dis 2017; 215: 1020
52 Computers Taking Over
53 Computers Taking Over
54 maybe not yet But computers may be able to help out Deep learning is a form of machine learning in which computers simulate the networks in human brains Basis for self-driving cars, for example Can this type of technology help with TB care?
55 Deep Learning and Chest Radiography Used publicly available datasets of TB CXRs from Thomas Jefferson University, NIH, Shenzhen, China, and Belarus Downloaded films and examined them using two deep convolutional neural net architectures AlexNet GoogLeNet Radiology 2017; 284: 574
56 Deep Learning and Chest Radiography Total of 1007 posteroanterior films Split films into training, validation, and test sets 150 films in test set, of which 75 had TB, 75 did not In cases where the two classifiers disagreed, an independent radiologist reviewed the films Radiology 2017; 284: 574
57
58 Deep Learning and Chest Radiography Radiology 2017; 284: 574
59 Deep Learning and Chest Radiography Neural net performance improved with training Test scenario designed to operate in TBendemic regions and differentiate normal from abnormal films Not ready for prime time, but could be useful in areas with limited radiologist availability Radiology 2017; 284: 574
60 Late Positive Smears Seem to be encountered with some frequency Do we have to put these patients back on isolation?
61 Late Positive Smears Retrospective cohort of 1611 patients with drug-susceptible pulmonary TB in South Korea Received standard TB treatment from January 2009-February 2014 Compared 41 patients (2.5%) who were smear-positive after 5 months of treatment to 123 age- and sex-matched controls Kang et al., Medicine 2016; 95: 31 (e4540)
62 Kang et al., Medicine 2016; 95: 31 (e4540)
63 Late Positive Smears Patients with late-positive smears were More likely to have prior TB (24.4% vs 12.2%) More likely to have presented with cough and dyspnea More likely to have initial positive smears (68% vs 44.7%) More likely to have cavity/bilateral disease and pleural effusions Kang et al., Medicine 2016; 95: 31 (e4540)
64 Late Positive Smears Kang et al., Medicine 2016; 95: 31 (e4540)
65 Late Positive Smears Only 1/41 (2.4%) of patients with late positive smears actually grew TB from culture 7 (17.1%) grew NTM The rest (80.5%) had negative cultures (although 6 patients had subsequent growth of NTM in other specimens) Kang et al., Medicine 2016; 95: 31 (e4540)
66 Late Positive Smears Only 1 patient (2.4%) was characterized as treatment failure, no acquired resistance The rest completed treatment successfully Prior studies reported % of pulmonary TB patients were smear-positive at month 5 Few culture positive These studies included some drug-resistant pts Kang et al., Medicine 2016; 95: 31 (e4540)
67 Late Positive Smears Most patients with late positive smears are not failing treatment No need in most cases to re-isolate In cases of suboptimal clinical response or known drug resistance, can consider more aggressive actions Kang et al., Medicine 2016; 95: 31 (e4540)
68 TB in Pregnancy Emerging Problem? Whether pregnancy increases risk of TB reactivation is debated TB has been associated with increased rates of pregnancy complications Treatment of TB in pregnancy is a bit more challenging because in US we avoid PZA
69 TB in Pregnancy Emerging Problem? Examined the Nationwide Inpatient Sample databases from % stratified sample of all discharges from US community hospitals About 7 million admissions from >1000 hospitals El-Messidi et al, Am J Obstet Gynecol 2016; 217: 797.e1-6
70 TB in Pregnancy Emerging Problem? Used ICD codes to identify deliveries and TB Also used these codes to identify comorbidities and obstetric outcomes 2064 births to women with TB identified during the 9 year study Women with TB more likely to be Hispanic (34.6% vs 19.1%) and HIV-infected (1.8% vs 0.1%) El-Messidi et al, Am J Obstet Gynecol 2016; 217: 797.e1-6
71 TB in Pregnancy Emerging Problem? El-Messidi et al, Am J Obstet Gynecol 2016; 217: 797.e1-6
72 TB in Pregnancy Emerging Problem? El-Messidi et al, Am J Obstet Gynecol 2016; 217: 797.e1-6
73 TB in Pregnancy Emerging Problem? Women with TB were more likely to have pregnancy complications: Chorioamnionitis Postpartum anemia Pulmonary complications (pneumonia/ards) Mortality (adjusted OR 6.27, 95% CI ) El-Messidi et al, Am J Obstet Gynecol 2016; 217: 797.e1-6
74 TB in Pregnancy Emerging Problem? Women with TB were more likely to have babies with congenital anomalies (adjusted odds ratio 1.80, 95% CI ) No difference in fetal growth, preterm birth, or stillbirth El-Messidi et al, Am J Obstet Gynecol 2016; 217: 797.e1-6
75 TB in Pregnancy Emerging Problem? TB and pregnancy a bad combination Not clear why the reported rise in the setting of otherwise falling US TB rates Screening high-risk women of reproductive age for TB and treatment for LTBI seems like a good idea El-Messidi et al, Am J Obstet Gynecol 2016; 217: 797.e1-6
76 Conclusions Lots of interesting new information in TB Treatment of latent TB is an important focus to move toward elimination New high-tech tools may help us move forward Old problems like TB in pregnancy still persist
State of the State in TB Control
State of the State in TB Control Jason Stout, MD, MHS Wake County TB Medical Consultant NC TB Medical Director Division of Infectious Diseases, Duke University Medical Center Disclosures-Funding NIH (grant)
More informationContact Investigation and Prevention in the USA
Contact Investigation and Prevention in the USA George D. McSherry, MD Division of Infectious Disease Penn State Children s Hospital Pediatric Section TB Center of Excellence Rutgers Global Tuberculosis
More informationTB: Management in an era of multiple drug resistance. Bob Belknap M.D. Denver Public Health November 2012
TB: Management in an era of multiple drug resistance Bob Belknap M.D. Denver Public Health November 2012 Objectives: 1. Explain the steps for diagnosing latent and active TB role of interferon-gamma release
More informationDiagnosis and Medical Management of TB Infection Lisa Y. Armitige, MD, PhD September 12, TB Nurse Case Management September 12 14, 2017
Diagnosis and Medical Management of TB Infection Lisa Y. Armitige, MD, PhD September 12, 2017 TB Nurse Case Management September 12 14, 2017 EXCELLENCE EXPERTISE INNOVATION Lisa Y. Armitige, MD, PhD has
More informationWhen Can Isolation Be Discontinued?
When Can Isolation Be Discontinued? - It Depends on the Patient and the Setting. Masae Kawamura M.D. and Barbara Seaworth M.D. Texas: (800) TEX-LUNG New Jersey: 973-972-3270? HNTC Consultation Line California:
More informationTB In Detroit 2011* Early TB: Smudge Sign. Who is at risk for exposure to or infection with TB? Who is at risk for TB after exposure or infection?
Those oral antibiotics are just not working! Inpatient Standards of Care & Discharge Planning S/He s in the Hospital: Now What Do I Do? Dana G. Kissner, MD TB Intensive Workshop, Lansing, MI 2012 Objectives:
More informationPediatric Tuberculosis in Los Angeles County: An Update
Pediatric Tuberculosis in Los Angeles County: An Update Julie Higashi, MD PhD Director, Tuberculosis Control Program March 2, 2019 0 Pediatricians will be the driving force of TB elimination in California
More informationDiagnosis and Medical Management of Latent TB Infection
Diagnosis and Medical Management of Latent TB Infection Marsha Majors, RN September 7, 2017 TB Contact Investigation 101 September 6 7, 2017 Little Rock, AR EXCELLENCE EXPERTISE INNOVATION Marsha Majors,
More informationContact Investigation
Tuberculosis Ann Raftery, RN, PHN, MSc GHS Learning Objectives Upon completion of this session, participants will be able to: Describe the criteria used and method for determining the infectious period
More informationDetection and Treatment of Tuberculosis in Correctional Facilities: Opportunities and Challenges
Detection and Treatment of Tuberculosis in Correctional Facilities: Opportunities and Challenges David Karol, MD, MA Bureau of Prisons, FMC Butner Duke University Medical Center June 26, 2013 No Disclosures
More informationLatent TB, TB and the Role of the Health Department
Latent TB, TB and the Role of the Health Department Elaine Darnall, RN, BSN, CIC TB Nurse Consultant Illinois Dept of Public Health March 21, 2018 Elaine Darnall has disclosed that there is no actual or
More informationWhat you need to know about diagnosing and treating TB: a preventable, fatal disease. Bob Belknap M.D. Denver Public Health November 2014
What you need to know about diagnosing and treating TB: a preventable, fatal disease Bob Belknap M.D. Denver Public Health November 2014 The Critical First Step Consider TB in the Differential 1. Risks
More informationTB Epidemiology. Richard E. Chaisson, MD Johns Hopkins University Center for Tuberculosis Research
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike License. Your use of this material constitutes acceptance of that license and the conditions of use of materials on this
More information10/3/2017. Updates in Tuberculosis. Global Tuberculosis, WHO 2015 report. Objectives. Disclosures. I have nothing to disclose
Disclosures Updates in Tuberculosis I have nothing to disclose Chris Keh, MD Assistant Clinical Professor, Division of Infectious Diseases, UCSF TB Controller, TB Prevention and Control Program, Population
More informationCase Management of the TB/HIV Infected Patient
TB Nurse Case Management San Antonio, Texas December 8-10, 2009 Case Management of the TB/HIV Infected Patient Sarah Hoffman, MPH, MSN, ACRN December 9, 2009 TB/HIV: Considerations in the Care of the Coinfected
More informationTurning Off the Spigot Reducing Nosocomial Drug Resistant TB. Edward A. Nardell, MD Harvard Medical School/PIH Brigham & Women s Hospital
Turning Off the Spigot Reducing Nosocomial Drug Resistant Transmission Edward A. Nardell, MD Harvard Medical School/PIH Brigham & Women s Hospital is an airborne infection Every case of MDR/XDR prevented
More informationThe Role of Rifampin for the Treatment of Latent TB Infection. Introduction. Introduction
The Role of Rifampin for the Treatment of Latent TB Infection March 26, 2008 Alfred A. Lardizabal, MD Associate Professor of Medicine New Jersey Medical School Global Tuberculosis institute Treatment of
More information11/1/2017. Disclosures. Update In Tuberculosis, Indiana Outline/Objectives. Pathogenesis of M.tb Global/U.S. TB Burden, 2016
Disclosures Update In Tuberculosis, Indiana 2017 Bradley Allen, MD, PhD, FACP, FIDSA Indiana University School of Medicine Division of Infectious Diseases Roudebush VAMC Indianapolis Medical Consultant,
More informationTransmission of DS-TB and MDR-TB. C. Robert Horsburgh, Jr. Boston University School of Public Health
Transmission of DS-TB and MDR-TB C. Robert Horsburgh, Jr. Boston University School of Public Health Outline Epidemiologic factors in transmission Ability of the transmitter to transmit Susceptibility of
More informationANNUAL TUBERCULOSIS REPORT OREGON Oregon Health Authority Public Health Division TB Program November 2012
ANNUAL TUBERCULOSIS REPORT OREGON 211 Oregon Health Authority Public Health Division TB Program November 212 Page 2 Table of Contents Charts Chart 1 TB Incidence in the US and Oregon, 1985-211... page
More informationDiagnosis & Medical Case Management of TB Disease. Lisa Armitige, MD, PhD October 22, 2015
Diagnosis & Medical Case Management of TB Disease Lisa Armitige, MD, PhD October 22, 2015 Comprehensive Care of Patients with Tuberculosis and Their Contacts October 19 22, 2015 Wichita, KS EXCELLENCE
More informationTuberculosis Intensive
Tuberculosis Intensive San Antonio, Texas April 3 6, 2012 Childhood Tuberculosis Kim Smith, MD, MPH April 6, 2012 Kim Smith, MD, MPH has the following disclosures to make: No conflict of interests No relevant
More informationLTBI: Who to Test & When to Treat
LTBI: Who to Test & When to Treat TB Intensive May 10 th, 2016 David Horne, MD, MPH Harborview Medical Center University of Washington DISCLOSURES I have no disclosures or conflicts of interest to report
More informationErrors in Dx and Rx of TB
Errors in Dx and Rx of TB David Schlossberg, MD, FACP Professor of Medicine Temple University School of Medicine Medical Director, TB Control Program Philadelphia Department of Public Health TB Still a
More informationYakima Health District BULLETIN
Yakima Health District BULLETIN Summary Volume 13, Issue 1 February, 2014 Tuberculosis in Yakima County The rate of active tuberculosis (TB) in Yakima County has declined by about two-thirds over the past
More informationResearch in Tuberculosis: Translation into Practice
Case History Research in Tuberculosis: Translation into Practice This is a 6-year6 year-old Bosnian male, who presented to ER with one-week history of fever and occasional vomiting. No cough, difficulty
More informationTB Outbreak Investigation in Fishery Workers, Maryland. Cassandra Althauser PHASE Internship Maryland Department of Health and Human Hygiene
TB Outbreak Investigation in Fishery Workers, Maryland Cassandra Althauser PHASE Internship Maryland Department of Health and Human Hygiene Airborne Transmission Tuberculosis Small droplet nuclei (
More informationAnnual Tuberculosis Report Oregon 2007
Annual Tuberculosis Report Oregon 7 Oregon Department of Human Services Public Health Division TB Program April 8 Page 2 Table of Contents Charts Chart 1 TB Incidence in the US and Oregon, 1985-7.. page
More information5. HIV-positive individuals treated with INH should receive Pyridoxine (B6) 25 mg daily or 50 mg twice/thrice weekly on the same schedule as INH
V. TB and HIV/AIDS A. Standards of Treatment and Management The majority of TB treatment principles apply to persons with HIV/AIDS who require treatment for TB disease. The following points are either
More informationDisclosures. Updates in TB for the PCP: Opportunities for Prevention. Objectives PART 1: WHY TEST? 4/14/2016. None
Disclosures Updates in TB for the PCP: Opportunities for Prevention None Pennan Barry, MD, MPH Chief, Surveillance and Epidemiology, California TB Control Branch Assistant Clinical Professor, Division
More informationhas the following disclosures to make:
CLINICAL DIAGNOSIS AND MANAGEMENT OF TB DISEASE Annie Kizilbash MD, MPH September 22, 2015 TB Nurse Case Management September 22 24, 2015 San Antonio. TX EXCELLENCE EXPERTISE INNOVATION Annie Kizilbash
More informationJeffrey R. Starke, M.D. has the following disclosures to make:
AAP 2018 Red Book Tuberculosis: IGRAs and Treatment of TB Infection Jeffrey R. Starke, M.D. May 31, 2018 AAP 2018 Red Book Childhood Tuberculosis: IGRAs and Treatment of TB Infection May 31, 2018 WEBINAR
More informationExpanding Latent Tuberculosis Infection Testing and Treatment to Accelerate Tuberculosis Elimination
IUATLD North American Region Conference February 24, 2017 Vancouver, BC Expanding Latent Tuberculosis Infection Testing and Treatment to Accelerate Tuberculosis Elimination Philip LoBue, MD National Center
More informationThe Public Health Impact of TB in the Correctional System. Sarah Bur, RN, MPH Federal Bureau of Prisons Infection Prevention and Control Officer
The Public Health Impact of TB in the Correctional System Sarah Bur, RN, MPH Federal Bureau of Prisons Infection Prevention and Control Officer The Public Health Impact of TB in the Correctional System
More informationTUBERCULOSIS. Presented By: Public Health Madison & Dane County
TUBERCULOSIS Presented By: Public Health Madison & Dane County What is Tuberculosis? Tuberculosis, or TB, is a disease caused by a bacteria called Mycobacterium tuberculosis. The bacteria can attack any
More informationTuberculosis Populations at Risk
Tuberculosis Populations at Risk One-third of the world is infected with TB, an average of one new infection per second Two million people died from tuberculosis in 2010, 1 every 20 seconds TB is the leading
More informationGuidance for Identifying Risk Factors for Mycobacterium tuberculosis (MTB) During Evaluation of Potential Living Kidney Donors
Summary and Goals On November 13, 2012, the OPTN/UNOS Board of Directors approved a requirement that all potential living kidney donors undergo evaluation for infection with Mycobacterium tuberculosis
More informationLatent Tuberculosis Infections Controversies in Diagnosis and Management Update 2016
Latent Tuberculosis Infections Controversies in Diagnosis and Management Update 2016 Randy Culpepper, MD, MPH Deputy Heath Officer/Medical Director Frederick County Health Department March 16, 2016 2 No
More informationNew Tuberculosis Guidelines. Jason Stout, MD, MHS
New Tuberculosis Guidelines Jason Stout, MD, MHS Two New Sets of Guidelines Treatment of Drug-Susceptible Tuberculosis Clinical Infectious Diseases 2016; 63(7): e147-e195 Diagnosis of Tuberculosis in Adults
More informationDIAGNOSIS AND MEDICAL MANAGEMENT OF TB DISEASE
DIAGNOSIS AND MEDICAL MANAGEMENT OF TB DISEASE Annie Kizilbash MD, MPH Assistant Professor University of Texas Health Science Center Staff Physician, Texas Center for Infectious Diseases TB Nurse Case
More informationScott Lindquist MD MPH Tuberculosis Medical Consultant Washington State DOH and Kitsap County Health Officer
Tuberculosis in the 21 st Century Scott Lindquist MD MPH Tuberculosis Medical Consultant Washington State DOH and Kitsap County Health Officer Feedback Poll In my opinion, the recent media coverage of
More informationLatent Tuberculosis Infection (LTBI) Questions and Answers for Health Care Providers
Latent Tuberculosis Infection (LTBI) Questions and Answers for Health Care Providers Who Should Be Screened for Latent Tuberculosis Infection (LTBI)?... 2 What tests are used to screen for LTBI?... 2 How
More informationPediatric TB Lisa Armitige, MD, PhD September 28, 2011
TB Nurse Case Management Davenport, Iowa September 27 28, 2011 Pediatric TB Lisa Armitige, MD, PhD September 28, 2011 Lisa Armitige, MD, PhD has the following disclosures to make: No conflict of interest.
More informationTreatment of TB Infection Lisa Y. Armitige, MD, PhD April 7, 2015
Treatment of TB Infection Lisa Y. Armitige, MD, PhD April 7, 2015 Tuberculosis Infection Diagnosis and Treatment April 7, 2015 El Paso, TX EXCELLENCE EXPERTISE INNOVATION Lisa Y. Armitige, MD, PhD has
More informationPre-Treatment Evaluation. Treatment of Latent TB Infection (LTBI) Initiating Treatment: Patient Education. Before initiating treatment for LTBI:
Pre-Treatment Evaluation Before initiating treatment for LTBI: Treatment of Latent TB Infection (LTBI) Amee Patrawalla, MD Associate Professor, New Jersey Medical School Attending Physician, NJMS Global
More informationTB Nurse Case Management San Antonio, Texas July 18 20, 2012
TB Nurse Case Management San Antonio, Texas July 18 20, 2012 Pediatric TB Kim Smith, MD, MPH July 19, 2012 Kim Smith, MD, MPH has the following disclosures to make: No conflict of interests No relevant
More informationDiagnosis and Treatment of Tuberculosis, 2011
Diagnosis of TB Diagnosis and Treatment of Tuberculosis, 2011 Alfred Lardizabal, MD NJMS Global Tuberculosis Institute Diagnosis of TB, 2011 Diagnosis follows Suspicion When should we Think TB? Who is
More informationIsoniazid Prevention Therapy for HIV Positive Patients
Isoniazid Prevention Therapy for HIV Positive Patients Increasing Tuberculosis Prevention for HIV-Patients in Ethiopia QuickTime and a decompressor are needed to see this picture. Ashok Reddy, MD University
More informationUtilizing All the Tools in the TB Toolbox
Utilizing All the Tools in the TB Toolbox Sandra Morano, B.A., R.N. Public Health Nurse, City of Stamford, CT TB Talk The New England TB Consortium March 18, 2010 Background TB Program, City of Stamford,
More informationTB Intensive San Antonio, Texas December 1-3, 2010
TB Intensive San Antonio, Texas December 1-3, 2010 TB Case Presentations Doug Hornick, MD; Iowa U Medical School December 1, 2010 Pulmonary Fascinomas with a Tuberculous Attitude Douglas B. Hornick, MD
More informationTB in Prisons and Jails Albuquerque, New Mexico November 28, 2012
TB in Prisons and Jails Albuquerque, New Mexico November 28, 2012 Challenges of TB Treatment in Special Populations in Corrections Marcos Burgos, MD November 28, 2012 Marcos Burgos, MD has the following
More informationPediatric TB Intensive Houston, Texas October 14, 2013
Pediatric TB Intensive Houston, Texas October 14, 2013 Diagnosis and Management of Tuberculosis in Adolescents Andrea T. Cruz, MD, MPH Sections of Infectious Diseases & Emergency Medicine October 14, 2013
More informationTB Update: March 2012
TB Update: March 2012 David Schlossberg, MD, FACP Medical Director, TB Control Program Philadelphia Department of Public Health 1 TB Update: March 2012 IGRAs vs TST LTBI A New Regimen NAATs What is Their
More informationKristina Wallengren, PhD MPH
Kristina Wallengren, PhD MPH Head of Clinical Research K-RITH South Africa K-RITH S AIM: TO CONDUCT EXCELLENT BASIC SCIENCE IN TB AND HIV XDR TB outbreak in Tugela Ferry, KwaZulu-Natal, 2005 XDR TB PREVALENCE
More informationTuberculosis Elimination
Tuberculosis Elimination Where We ve Been, Where We re Going Mark Lobato, MD New England TB Consultant Division of Tuberculosis Elimination Centers for Disease Control and Prevention Disclosures / Disclaimer
More informationSubstance Abuse and Tuberculosis Springfield, IL April 27, 2011
5/6/2011 Substance Abuse and Tuberculosis Springfield, IL April 27, 2011 Epidemiology of Substance Abuse and Tuberculosis: Where is the Problem? Debra Stephens, RN, BSN, MPH April 27, 2011 Debra Stephens,
More information2014 Annual Report Tuberculosis in Fresno County. Department of Public Health
214 Annual Report Tuberculosis in Fresno County Department of Public Health www.fcdph.org Tuberculosis (TB) is a common communicable disease caused by the bacterium Mycobacterium tuberculosis and occasionally
More informationChapter 5 Treatment for Latent Tuberculosis Infection
Chapter 5 Treatment for Latent Tuberculosis Infection Table of Contents Chapter Objectives.... 109 Introduction.... 111 Candidates for the Treatment of LTBI... 112 LTBI Treatment Regimens.... 118 LTBI
More informationLatent TB Infection Treatment
Latent TB Infection Treatment Douglas B. Hornick, MD Pulmonologist w/ Infectious Attitude Division of Pulmonary/Critical Care/Occ Med UI Carver College of Medicine 2014 MFMER slide-1 Disclosures: None
More informationCommunicable Disease Control Manual Chapter 4: Tuberculosis. Assessment and Follow-Up of TB Contacts
Provincial TB Services 655 West 12th Avenue Vancouver, BC V5Z 4R4 www.bccdc.ca Communicable Disease Control Manual Assessment and Follow-Up of TB July, 2018 Page 1 TABLE OF CONTENTS 8.0 ASSESSMENT AND
More informationDisclosures. Outline. No disclosures or conflicts of interest to report. Special LTBI situations. H t it d id ff t
Selected Topics in LTBI June 2, 2015 Bijan Ghassemieh, MD Senior Fellow UW Division of Pulmonary/Critical Care Disclosures No disclosures or conflicts of interest to report Outline Special LTBI situations
More informationTB-Free California: How close are we? How can we get closer?
TB-Free California: How close are we? How can we get closer? California TB Controllers Association April 21, 2015 Pennan Barry, MD, MPH Chief, Surveillance and Epidemiology Section Acknowledgments Local
More informationManagement of Patients with TB Infection Catalina Navarro, RN, BSN April 7, 2015
Management of Patients with TB Infection Catalina Navarro, RN, BSN April 7, 2015 Tuberculosis Infection Diagnosis and Treatment April 7, 2015 El Paso, TX EXCELLENCE EXPERTISE INNOVATION Catalina Navarro,
More informationHaley Blake Sage Nagai, MPH. Disease Investigation and Intervention Specialists Tuberculosis Treatment and Control Clinic
Haley Blake Sage Nagai, MPH Disease Investigation and Intervention Specialists Tuberculosis Treatment and Control Clinic Discuss the prevalence of tuberculosis in Clark County Describe factors influencing
More informationGlobal Perspective on Transmission: Value in Genotype Mapping of Disease Transmission Dynamics
Global Perspective on Transmission: Value in Genotype Mapping of Disease Transmission Dynamics Neel R. Gandhi, MD Emory Rollins School of Public Health January 17, 2013 Medical Research Council BMJ 1948
More informationMycobacterial Infections: What the Primary Provider Should Know about Tuberculosis
Mycobacterial Infections: What the Primary Provider Should Know about Tuberculosis Henry F. Chambers, M.D Professor of Medicine, UCSF Topics for Discussion Epidemiology Diagnosis of active TB Screening
More information2016 Annual Tuberculosis Report For Fresno County
206 Annual Tuberculosis Report For Fresno County Cases Rate per 00,000 people 206 Tuberculosis Annual Report Fresno County Department of Public Health (FCDPH) Tuberculosis Control Program Tuberculosis
More informationTB Intensive Houston, Texas. Childhood Tuberculosis Kim Connelly Smith. November 12, 2009
TB Intensive Houston, Texas November 10-12, 12 2009 Childhood Tuberculosis Kim Connelly Smith MD, MPH November 12, 2009 Childhood Tuberculosis Kim Connelly Smith MD, MPH November 12, 2009 1 OUTLINE Stages
More informationTuberculosis Intensive November 17 20, 2015 San Antonio, TX
Treatment of Tuberculosis Elizabeth S. Guy, MD November 17, 2015 Tuberculosis Intensive November 17 20, 2015 San Antonio, TX EXCELLENCE EXPERTISE INNOVATION Elizabeth S. Guy, MD has the following disclosures
More informationTB Nurse Case Management San Antonio, Texas March 7 9, Pediatric TB Kim Connelly Smith, MD, MPH March 8, 2012
TB Nurse Case Management San Antonio, Texas March 7 9, 2012 Pediatric TB Kim Connelly Smith, MD, MPH March 8, 2012 Kim Connelly Smith, MD, MPH has the following disclosures to make: No conflict of interests
More informationDiagnosis and Medical Management of TB Disease. Quratulian Annie Kizilbash, MD, MPH March 17, 2015
Diagnosis and Medical Management of TB Disease Quratulian Annie Kizilbash, MD, MPH March 17, 2015 TB Nurse Case Management March 17 19, 2015 San Antonio, Texas EXCELLENCE EXPERTISE INNOVATION Quratulian
More informationFundamentals of Tuberculosis (TB)
TB in the United States Fundamentals of Tuberculosis (TB) From 1953 to 1984, reported cases decreased by approximately 5.6% each year From 1985 to 1992, reported cases increased by 20% 25,313 cases reported
More informationTB is Global. Latent TB Infection (LTBI) Sharing the Care: Working Together. September 24, 2014
Sharing the Care: Working Together to Meet the Challenge of TB Presented by: Barbara Cole, RN, PHN, MSN Director, Disease Control County of Riverside Department of Public Health Curry International TB
More informationTuberculosis Exposure, Infection, and Disease Among Children with Medical Comorbidities
Tuberculosis Exposure, Infection, and Disease Among Children with Medical Comorbidities Andrea T. Cruz, MD, MPH, Omar Merchant, Affan Zafar, and Jeffrey R. Starke, MD Department of Pediatrics February
More informationTB Nurse Case Management San Antonio, Texas April 9-11, 2013
TB Nurse Case Management San Antonio, Texas April 9-11, 2013 TB / Dose Counting Rachel Munoz, RN. TB Nurse Case Manager/Nurse Consultant Austin/Travis County Health Department April 10, 2013 Rachel Munoz,
More informationThe authors assessed drug susceptibility patterns
Drug Resistance Among Tuberculosis Patients, 1991 and 1992 New York City, CYNTHIA R. DRIVER, RN, MPH THOMAS R. FRIEDEN, MD, MPH ALAN B. BLOCH, MD, MPH IDA M. ONORATO, MD All the authors are with the Division
More informationIntensified TB case finding among PLHIV and vulnerable population Identifying contacts Gunta Kirvelaite
Intensified TB case finding among PLHIV and vulnerable population Identifying contacts Gunta Kirvelaite Riga East Clinical hospital, Centre for tuberculosis and lung diseases. Head of outpatient department.
More informationAdvanced Management of Patients with Tuberculosis Little Rock, Arkansas August 13 14, 2014
Advanced Management of Patients with Tuberculosis Little Rock, Arkansas August 13 14, 2014 Tuberculosis Pathogenesis and Treatment of Latent TB Infection Lisa Armitige, MD, PhD August 13, 2014 Lisa Armitige,
More informationTreatment of Active Tuberculosis
Treatment of Active Tuberculosis Jeremy Clain, MD Pulmonary & Critical Care Medicine Mayo Clinic October 16, 2017 2014 MFMER slide-1 Disclosures No relevant financial relationships No conflicts of interest
More informationTB trends and TB genotyping
Management of a TB Contact Investigation for Public Health Workers Albuquerque, NM October 1, 214 TB trends and TB genotyping Marcos Burgos MD October 1, 214 Marcos Burgos, MD has the following disclosures
More informationINDEX CASE INFORMATION
Instructions for Completing the MDH Tuberculosis Contact Investigation Report Form Please provide as much information as possible. Each field represents information that is important to the contact investigation.
More informationExperience with Pyrazinamide and Rifampin Regimens for Latent TB Infection
Experience with Pyrazinamide and Rifampin Regimens for Latent TB Infection Krista Powell, MD, MPH Co-Project Officer, National Surveillance for Severe Adverse Events Associated with LTBI Treatment Lead,
More informationInterpretation of TST & IGRA results. Objectives
Interpretation of TST & IGRA results Randall Reves, MD, MSc Volunteer Clinician Denver Metro TB Program and Division of Infectious Diseases, Department of Medicine University of Colorado Denver Objectives
More informationPlease distribute a copy of this information to each provider in your organization.
HEALTH ADVISORY TO: Physicians and other Healthcare Providers Please distribute a copy of this information to each provider in your organization. Questions regarding this information may be directed to
More informationTuberculosis in Primary Care COC GTA Spring Symposium Dr Elizabeth Rea April 2013
Tuberculosis in Primary Care COC GTA Spring Symposium Dr Elizabeth Rea April 2013 1 TB in Toronto - risk groups Diagnosis of active TB LTBI diagnosis and management Infection control 2 TB in Toronto Case
More informationTuberculosis: Where Are We Now?
Tuberculosis: Where Are We Now? Amee Patrawalla MD MPH Rutgers - NJ Medical School Global TB Institute Rutgers, The State University of New Jersey Learning Objectives Understand the current epidemiologic
More informationResponding to a TB Event Bismarck, North Dakota June 24-25, 2008
Responding to a TB Event Bismarck, North Dakota June 24-25, 2008 TB Epidemiology: Global and State Lynelle Phillips, RN, MPH June 24, 2008 TB Epidemiology Global and State Lynelle Phillips RN MPH Nurse
More informationLatent Tuberculosis Best Practices
Latent Tuberculosis Best Practices Last Updated September 7, 2016 LTBI Demographics in the US o 13million people in the US with LTBI (estimate) o In 2014, approximately 66% of TB cases in the United States
More informationTUBERCULOSIS CONTACT INVESTIGATION
TB CASE MANAGEMENT AND CONTACT INVESTIGATION INTENSIVE TUBERCULOSIS CONTACT INVESTIGATION LEARNING OBJECTIVES Upon completion of this session, participants will be able to: 1. Describe the criteria used
More informationContact Investigation San Antonio, Texas January 14-15, 2013
Contact Investigation San Antonio, Texas January 14-15, 2013 Detecting and Handling a TB Outbreak Jessica Quintero, BAAS January 15, 2013 Jessica Quintero, BAAS has the following disclosures to make: No
More informationTB in California: Costs, Transmission, and Selecting from the Latent Pool
TB in California: Costs, Transmission, and Selecting from the Latent Pool Pennan Barry, MD, MPH Tuberculosis Control Branch California Department of Public Health California Tuberculosis Controller s Association
More informationPediatric Tuberculosis Lisa Y. Armitige, MD, PhD September 14, 2017
Pediatric Tuberculosis Lisa Y. Armitige, MD, PhD September 14, 2017 TB Nurse Case Management September 12 14, 2017 EXCELLENCE EXPERTISE INNOVATION Lisa Y. Armitige, MD, PhD has the following disclosures
More informationTB in Corrections Phoenix, Arizona
TB in Corrections Phoenix, Arizona March 24, 2011 Treatment of Latent TB Infection Renuka Khurana MD, MPH March 24, 2011 Renuka Khurana, MD, MPH has the following disclosures to make: No conflict of interests
More informationTB Contact Investigation
Ann Raftery, RN, PHN, MS Curry International TB Center Overview Contact investigation as a core TB control and elimination activity Components of TB Contact Investigation TB Control Priority Strategies.
More informationDrug Interactions Lisa Armitige, MD, PhD November 17, 2010
Substance Abuse and Tuberculosis Oklahoma City, Oklahoma November 17, 2010 Drug Interactions Lisa Armitige, MD, PhD November 17, 2010 Drug Interactions Lisa Y. Armitige, M.D., Ph.D. Medical Consultant
More informationArizona Annual Tuberculosis Surveillance Report
Arizona Annual Tuberculosis Surveillance Report 2014 Table of Contents I. Executive Summary 1 II. Case Rates 3 III. Cases and Case Rates by Race and Ethnicity 4 IV. Cases by Gender 4 V. Cases and Case
More informationMULTIDRUG- RESISTANT TUBERCULOSIS. Dean Tsukayama Hennepin County Medical Center Hennepin County Public Health Clinic
MULTIDRUG- RESISTANT TUBERCULOSIS Dean Tsukayama Hennepin County Medical Center Hennepin County Public Health Clinic I have no relevant financial relationships. Discussion includes off label use of: amikacin
More informationINH Prophylaxis Therapy (IPT) should NOT be implemented for all HIV patients in the Asia Pacific
INH Prophylaxis Therapy (IPT) should NOT be implemented for all HIV patients in the Asia Pacific Thuy Le, MD DPhil Duke University School of Medicine, USA Oxford University Clinical Research Unit Hospital
More informationHEALTH SERVICES POLICY & PROCEDURE MANUAL
PAGE 1 of 7 References Related ACA Standards 4 th Edition Standards for Adult Correctional Institutions 4-4350, 4-4355 These guidelines are based on the recommendations of the American Thoracic Society
More informationMoving Past the Basics of Tuberculosis Phoenix, Arizona May 8-10, 2012
Moving Past the Basics of Tuberculosis Phoenix, Arizona May 8-10, 2012 LTBI and TB Disease Treatment Cara Christ, MD, MS May 8, 2012 Cara Christ, MD, MS has the following disclosures to make: No conflict
More information